TG THERAPEUTICS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Tg Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • Tg Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was $3.88M, a 96.6% decline year-over-year.
  • Tg Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$14.4M, a 44.6% increase year-over-year.
  • Tg Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $12.7M.
  • Tg Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$198M, a 43% increase from 2021.
  • Tg Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$348M.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$14.4M $3.88M -$110M -96.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $95.7M $6.88M +$54.5M Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 $41.2M -$10.7M +$28.5M +72.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 $12.7M -$14.4M +$38.6M +72.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 -$25.9M $114M +$150M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$176M -$47.6M -$7.1M -17.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$169M -$39.2M +$29.8M +43.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$198M -$53M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 -$35.8M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$40.5M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-06
Q1 2022 -$69M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-06
Q4 2019 -$173M -$39.6M +$14.3M +26.5% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-02
Q3 2019 -$187M -$61.9M -$28M -82.4% Jul 1, 2019 Sep 30, 2019 10-K 2020-03-02
Q2 2019 -$159M -$36.2M +$7.93M +18% Apr 1, 2019 Jun 30, 2019 10-K 2020-03-02
Q1 2019 -$167M -$35.2M +$6.37M +15.3% Jan 1, 2019 Mar 31, 2019 10-K 2020-03-02
Q4 2018 -$173M -$53.9M -$23M -74.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$150M -$34M -$2.42M -7.66% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-02
Q2 2018 -$148M -$44.1M -$15.8M -55.7% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-02
Q1 2018 -$132M -$41.5M -$13.8M -49.8% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-02
Q4 2017 -$118M -$30.9M -$7.19M -30.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$111M -$31.5M -$6.7M -27% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$105M -$28.4M -$12.5M -78.3% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$92.1M -$27.7M -$13.9M -100% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$78.3M -$23.7M -$6.06M -34.4% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 -$72.2M -$24.8M -$11.2M -81.8% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-15
Q2 2016 -$61M -$15.9M +$1.2M +7.04% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-15
Q1 2016 -$62.2M -$13.8M +$729K +5% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-15
Q4 2015 -$62.9M -$17.6M +$1.18M +6.3% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-16
Q3 2015 -$64.1M -$13.7M +$3.8M +21.7% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-16
Q2 2015 -$67.9M -$17.1M -$5.12M -42.7% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-16
Q1 2015 -$62.8M -$14.6M -$7.03M -93.2% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-16
Q4 2014 -$55.8M -$18.8M -$13.1M -232% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$42.6M -$17.5M -$12.9M -283% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$29.8M -$12M -$5.4M -82% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$24.4M -$7.55M -$3.87M -105% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$20.5M -$5.66M -$2.2M -63.7% Oct 1, 2013 Dec 31, 2013 10-K 2014-03-07
Q3 2013 -$18.3M -$4.56M -$2.09M -85% Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-14
Q2 2013 -$16.2M -$6.58M -$4.69M -248% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-09
Q1 2013 -$11.5M -$3.67M +$6.58M +64.2% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$18.1M -$3.46M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-07
Q3 2012 -$2.46M -$2.43M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$1.89M -$1.61M -572% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$10.3M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q3 2011 -$28.6K* -$69.9K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$282K -$2.13M -115% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-07
Q3 2010 $41.2K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 $1.85M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.